NAD+ supplement evidence is real — and honestly more nuanced than your social feed admits.
The IV Drip Moment Nobody Saw Coming
In May 2026, NPR published a major investigative piece on the IV drip wellness industry. The story examined how celebrity-endorsed NAD+ infusions had gone mainstream — glossy clinic photos, social posts showing arms connected to IV bags, breathless testimonials about feeling decades younger. NPR asked the question the wellness world had been avoiding: Does any of this actually work?
That report landed differently than most wellness skeptic pieces. NPR is not a fringe outlet. When credible investigative journalism puts a wellness category under a microscope, curious people — especially skeptical Gen X readers who already have a nose for hype — pay attention.
If you found this article because that story left you asking harder questions about NAD+ supplement evidence, good. Those are exactly the right questions. And you deserve an honest answer — not a sales pitch, not a dismissal.
Here is the short version: two things are both true, and the space between them is where all the real information lives.
What Is NAD+ and Why Do Researchers Care?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme — a molecule your cells rely on to carry out hundreds of chemical reactions. It sits at the center of the process by which your mitochondria (the energy-generating structures inside your cells) convert food into ATP, the actual fuel cells run on. Without adequate NAD+, this conversion process runs less efficiently.
NAD+ also plays a key role in activating sirtuins — a family of proteins sometimes called "longevity proteins" because of their involvement in cellular stress response, DNA repair, and metabolic regulation. When sirtuin signaling functions well, it is associated with better cellular maintenance. When it falters, researchers observe hallmarks associated with biological aging.
The important piece: NAD+ levels measurably decline with age. Studies in animal models show this decline is substantial and consistent. Human data confirms the same trend — meaningfully lower NAD+ in older adults compared to younger ones. This biological reality is not controversial. It is the legitimate scientific foundation on which the entire supplement category is built.
The controversy is about what happens when you try to reverse that decline.
The Mouse Model Problem: Where Most of the Hype Lives
The strongest NAD+-related findings come from animal studies — particularly rodent models. Mice given NAD+ precursors like NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside — a form of vitamin B3) have shown impressive results: better physical endurance, improved insulin sensitivity, some early signals for cognitive protection, and in certain studies, extended lifespan.
These findings are real. They are also bounded by one enormous constraint: mice are not people.
Animal studies are how science builds hypotheses. They are essential, and they are the reason serious researchers began studying NAD+ in human subjects at all. But the translation from mouse models to human outcomes is consistently more modest and more mixed than the headlines suggest. This gap — between what works convincingly in rodents and what we know works in people — is where most of the NAD+ hype lives.
Anyone selling dramatic human outcomes based primarily on animal data is using the research to imply a conclusion it does not support.
What Human Trials Actually Show About NAD+ Supplement Evidence
Here is what the peer-reviewed human evidence actually says. Let's be precise.
Blood NAD+ elevation: consistently confirmed in humans. A landmark 2018 randomized controlled trial published in Nature Communications (PMID 29599478) found that chronic NR (nicotinamide riboside) supplementation significantly elevated whole-blood NAD+ levels in healthy middle-aged and older adults. This was a rigorously designed RCT — not a mouse study, not an in-vitro experiment. The mechanism works in people.
A 2023 multicenter RCT published in GeroScience (PMID 36482258) followed 80 healthy middle-aged adults taking NMN (nicotinamide mononucleotide) and found a dose-dependent increase in blood NAD+ levels. Again: oral supplementation demonstrably raises NAD+ in the human bloodstream.
Safety profile: well-documented. A 2023 review in Advances in Nutrition (PMID 37619764) summarizing NMN human clinical trials found the compound safe across the doses studied. Long-term NR safety data from Scientific Reports (PMID 31278280) showed no concerning signals in healthy adults over an extended study period.
Functional outcomes in healthy adults: promising but still building. Here is the honest part that gets lost in wellness coverage. Raising blood NAD+ is measurable. Whether that elevation translates to the dramatic energy, cognition, and anti-aging outcomes frequently claimed for healthy adults — that is a more mixed, more preliminary picture. Some trials report modest improvements in specific measures like muscle function or fatigue scores. Others find no statistically significant difference versus placebo on subjective outcomes. The research is active and genuinely unresolved.
This is not a reason to dismiss the category. It is a reason to have calibrated expectations.
The IV Drip Question: What the Evidence Actually Covers
The format at the center of recent wellness media — intravenous NAD+ infusions — raises a specific evidentiary question. IV delivery bypasses the digestive system entirely, which proponents argue produces higher bioavailability.
What does the evidence say? There is currently no published randomized controlled trial demonstrating that IV NAD+ delivery outperforms oral supplementation in healthy adults on any meaningful functional outcome. The human RCT literature that exists — including the Nature Communications and GeroScience trials cited above — is built on oral NR and NMN.
That does not mean IV delivery is ineffective. It means the clinical evidence base for oral supplementation is substantially better documented than the evidence for intravenous delivery in healthy people. The IV format commands dramatically higher costs for an experience with, at best, less established human data than the pill form — at least as of the published literature through mid-2026.
What This Means Practically — NAD+ vs. Hype
Pulling this together honestly:
- NAD+ declines with age. Well-established biology.
- Oral NR and NMN supplementation reliably raises blood NAD+ in humans. Multiple RCTs support this.
- The safety profile of both NR and NMN at studied doses is well-documented in published trials.
- Whether raising NAD+ produces measurable functional benefits in healthy adults — cellular energy support, cognitive clarity, longevity — remains an active and genuinely open research question. The preclinical signals are compelling; the human functional data is promising and still accumulating.
- IV delivery has substantially less human evidence behind it than oral supplementation, at significantly higher cost.
For adults who understand this picture and want to support their NAD+ levels with a format that has real human safety and mechanism data, oral NR/NMN supplementation is a reasonable, evidence-grounded choice — not a miracle, and not a scam.
If you're looking for a practical starting point, ESB NAD+ is formulated to support healthy NAD+ levels* — built on the same NMN research reviewed here, without the price tag of a drip clinic. Learn more at Eternal Springs Bio.
\ These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.*
Want more of this? The Eternal Springs Bio newsletter translates the science of healthy aging into clear, practical insights every week — research you can actually act on. Subscribe to the Age Smarter Journal →
About the author — Roger Braun is the founder of Eternal Springs Bio, a NASM Certified Nutrition Coach, and a wellness entrepreneur with more than 14 years of experience in the dietary supplement industry. He earned his Bachelor's Degree in General Studies from Western Illinois University and has spent his career working with nutrition, supplement, and healthy-aging products.
Roger's writing focuses on the science of aging, metabolic health, gut health, immune support, and evidence-based nutrition strategies. He translates peer-reviewed research and supplement industry knowledge into clear, practical guidance for adults who want to better understand how nutrition, lifestyle, and targeted supplementation can support healthy aging in midlife and beyond.
Based on original ideas, research direction, and editorial review by the author, with AI-assisted drafting support.
Explore more articles on healthy aging and evidence-based nutrition in the Age Smarter Journal.
For more on cellular health, healthy aging, and the science behind the supplements: eternalspringsbio.com/blog
Informational Disclaimer: This article is for informational purposes only and is not medical advice. Do your own research and talk to your doctor before changing your diet, exercise routine, supplements, or health habits.
Product Disclaimer: The Food and Drug Administration has not evaluated these statements. If the above article mentions product(s), please know, These products are not intended to diagnose, treat, cure, or prevent any disease.